🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
25.80
-0.40 (-1.53%)
Nov 18, 2026, 12:56 PM EST - Market open

Vera Therapeutics Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Vera Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $71.36. The average 1-year stock price forecast is 176.59% higher than the current stock price, while the lowest is $29 (+12.40%) and the highest is $100 (+287.60%).

Price Target: $71.36 (+176.59%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$29$71.36$75$100
Change+12.40%+176.59%+190.70%+287.60%

Analyst Ratings

The average analyst rating for Vera Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy121212121111
Buy111111
Hold111122
Sell000000
Strong Sell000000
Total141414141414

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
J.P. Morgan
J.P. Morgan
Buy
Maintains
$83 → $75
BuyMaintains$83 → $75+190.70%Nov 13, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
n/a
BuyMaintainsn/an/aNov 7, 2026
Wedbush
Wedbush
Hold
Maintains
$34 → $29
HoldMaintains$34 → $29+12.40%Nov 6, 2026
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$100
BuyMaintains$100+287.60%Nov 6, 2026
Guggenheim
Guggenheim
Buy
Reiterates
$76 → $66
BuyReiterates$76 → $66+155.81%Nov 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
31.20M
Revenue Next Year
257.64M
from 31.20M
Increased by 725.78%
EPS This Year
-5.95
from -4.66
EPS Next Year
-3.92
from -5.95
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-----31.20M
Operating Income
-34.40M-90.90M-102.01M-167.17M-315.47M-430.34M
Net Income
-32.61M-89.06M-95.99M-152.15M-299.62M-423.60M
EPS
-----4.66-5.95
Free Cash Flow
-----241.73M-391.00M
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High42.5M
Avg31.2M
Low22.7M

Revenue Growth

Revenue Growth20272028
High
1,011.8%
Avg
725.8%
Low
473.7%

EPS Forecast

EPS202620272028
High-5.65
Avg-5.95
Low-6.61

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-